RELIEF THERAPEUTICS N/ CH0100191136 /
| 1/27/2023 2:46:17 PM | Chg. -0.0002 | Volume | Bid2:52:26 PM | Ask2:52:26 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.0294CHF | -0.68% | 1.54 mill. Turnover: 45,434.4262 |
0.0294Bid Size: 149,843 | 0.0297Ask Size: 80,047 | 127.74 mill.CHF | - | - |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.01 EUR | 233.33% |
| EPS Diluted: | -0.01 EUR | 233.33% |
| Revenues per Share: | 0.00 EUR | - |
| Book Value per Share: | 0.04 EUR | 99.29% |
| Cash Flow per Share: | -0.01 EUR | 43.51% |
| Dividend per Share: | 0.00 EUR | - |
| Total | in mill. | |
| Revenues: | 3.30 EUR | - |
| Net Income: | -34.30 EUR | 339.74% |
| Operating Cash Flow: | -35.70 EUR | - |
| Cash and Cash Equivalents: | 44.80 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 39.31 | 83.18 |
| P/BV ratio: | 0.71 | 1.51 |
| P/CF Ratio: | -3.63 | -7.69 |
| PEG: | -0.01 | - |
| Earnings Yield: | -34.02% | -16.08% |
| Dividend Yield: | 0.00% | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | 127.74 mill. CHF | 283.6 mill. CHF |
| Free Float Market Cap.: | 56.88 mill. CHF | 126.29 mill. CHF |
| Market Cap. / Employee: | - CHF | - CHF |
| Shares Outstanding: | 4.41 bill. | |
Profitability
| Gross Profit Margin: | -176.39% |
| EBIT Margin: | -1,039.39% |
| Net Profit Margin: | -1,039.39% |
| Return on Equity: | -18.90% |
| Return on Assets: | -13.63% |
Financial Strength
| Liquidity I / Cash Ratio: | 227.41% |
| Liquidity II / Quick Ratio: | 234.01% |
| Liquidity III / Current Ratio: | 279.19% |
| Debt / Equity Ratio: | 38.62% |
| Dynam. Debt / Equity Ratio: | -196.36% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | - EUR |
| Net Income / Employee: | - EUR |
| Total Assets / Employee: | - EUR |
| * Fiscal Year End: | 12/31/2021 |
| Accounting Standard: | IFRS |
| Currency: | EUR |